PT838680E - Determinacao de antigenios complexados especificos da prostata - Google Patents

Determinacao de antigenios complexados especificos da prostata

Info

Publication number
PT838680E
PT838680E PT97117672T PT97117672T PT838680E PT 838680 E PT838680 E PT 838680E PT 97117672 T PT97117672 T PT 97117672T PT 97117672 T PT97117672 T PT 97117672T PT 838680 E PT838680 E PT 838680E
Authority
PT
Portugal
Prior art keywords
fpsa
antibody
specific
cpsa
binding
Prior art date
Application number
PT97117672T
Other languages
English (en)
Inventor
William Jeffrey Allard
Kwok K Yeung
Zeqi Zhou
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT838680(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT838680E publication Critical patent/PT838680E/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT97117672T 1996-10-25 1997-10-13 Determinacao de antigenios complexados especificos da prostata PT838680E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US83496997A 1997-04-07 1997-04-07
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA

Publications (1)

Publication Number Publication Date
PT838680E true PT838680E (pt) 2004-08-31

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97117672T PT838680E (pt) 1996-10-25 1997-10-13 Determinacao de antigenios complexados especificos da prostata

Country Status (14)

Country Link
US (2) US5928878A (pt)
EP (1) EP0838680B1 (pt)
JP (1) JP4274330B2 (pt)
AT (1) ATE267399T1 (pt)
AU (1) AU746345B2 (pt)
CA (1) CA2214488C (pt)
CZ (1) CZ295854B6 (pt)
DE (1) DE69729156T2 (pt)
DK (1) DK0838680T3 (pt)
ES (1) ES2221006T3 (pt)
HU (1) HU221350B1 (pt)
IL (1) IL121659A (pt)
NO (1) NO974534L (pt)
PT (1) PT838680E (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
WO1999033878A1 (fr) * 1997-12-25 1999-07-08 Japan Tobacco Inc. Anticorps monoclonal contre le facteur de croissance du tissu conjonctif et ses mises en applications medicales
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 HIV−1p24抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
EP1178317B1 (en) 2000-07-24 2004-11-10 Health Research, Inc. Method for detection of prostate specific membrane antigen in serum
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
US7189504B2 (en) 2000-08-07 2007-03-13 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
ES2268387T3 (es) * 2002-03-13 2007-03-16 Biomerieux Procedimiento de deteccion y de cuantificacion de celulas tumorales circulantes, procedentes de canceres solidos.
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (en) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Method for detecting low levels of a fusion protein
ES2314624T3 (es) * 2004-01-28 2009-03-16 Turun Yliopisto Metodo mejorado para el diagnostico del sindrome coronario agudo.
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (en) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
JP5415520B2 (ja) * 2008-04-09 2014-02-12 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最大酸素消費量低下の予測のためのプロ−エンドセリン−1
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 N型糖鎖が付加している膵臓リボヌクレアーゼ1の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下1▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (en) * 1993-07-22 1995-01-25 Wallac Oy Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
HUP9701717A2 (hu) 1998-05-28
HU9701717D0 (en) 1997-12-29
US5928878A (en) 1999-07-27
DE69729156T2 (de) 2005-05-25
NO974534L (no) 1998-04-27
EP0838680A1 (en) 1998-04-29
ATE267399T1 (de) 2004-06-15
CZ295854B6 (cs) 2005-11-16
AU746345B2 (en) 2002-04-18
EP0838680B1 (en) 2004-05-19
DK0838680T3 (da) 2004-09-27
NO974534D0 (no) 1997-10-01
CA2214488C (en) 2007-06-19
CZ335797A3 (cs) 1998-05-13
IL121659A (en) 2000-07-16
IL121659A0 (en) 1998-02-22
AU3926797A (en) 1998-04-30
HUP9701717A3 (en) 2000-04-28
JPH10177027A (ja) 1998-06-30
DE69729156D1 (de) 2004-06-24
US6107049A (en) 2000-08-22
JP4274330B2 (ja) 2009-06-03
HU221350B1 (en) 2002-09-28
CA2214488A1 (en) 1998-04-25
ES2221006T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
PT838680E (pt) Determinacao de antigenios complexados especificos da prostata
CY1115366T1 (el) Δεικτες ογκου
CA2384579A1 (en) Early cancer tumor marker
EP1137943A1 (en) Cancer detection method and reagents
JP2002532686A5 (pt)
WO2011074802A2 (ko) 전립선암 진단용 키트 및 진단방법
KR890015714A (ko) 폐암의 조기 검출 방법
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
Basu et al. Lectin and serum-PSA interaction as a screening test for prostate cancer
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
NZ335535A (en) Immunohistochemical assay for carcinoma proliferative status by detecting presence of NGAL protein
DE69811157D1 (de) Immunoassay zur Bestimmung von PSA-ACT
JP5048207B2 (ja) 敗血症状態の発症および存在を決定するための装置及び方法
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
Christofidis Scientific background of the project
Christofidis Scientific background of the project [Radioimmunometric assay for Prostate Specific Antigen (PSA) measurement]
DE69616509D1 (de) A-protein als diagnostikum für krebs
Lynch et al. An Enzyme Immunoassay for Carcinoembryonic Antigen Which Employs Simultaneous Incubation of Specimen with Solid Phase and Enzyme-Conjugated Antibodies
KR20080040306A (ko) 현장검사용 암 진단 시스템
ITMI962054A1 (it) Saggio per la determinazione di anticorpi anti-endomisio